Global Pulmonary Arterial Hypertension Market Share

Market Share of Global Pulmonary Arterial Hypertension Industry

The Pulmonary Arterial Hypertension Market is fragmented and competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. The leading players in the global market for Pulmonary Arterial Hypertension are - Arena Pharmaceuticals, Bayer AG, Bristol-Myers Squibb Company, Gilead Sciences, Inc., GlaxoSmithKline Plc, Johnson & Johnson (Actelion Pharmaceuticals, Ltd.), Merck & Co. Inc., Novartis International AG, Pfizer, Inc., and United Therapeutics Corporation.

Pulmonary Arterial Hypertension (PAH) Market Leaders

1. Bayer AG

2. Gilead Sciences, Inc.

3. Johnson & Johnson (Actelion Pharmaceuticals, Ltd.)

4. Pfizer, Inc.

5. United Therapeutics Corporation

*Disclaimer: Major Players sorted in no particular order